421 related articles for article (PubMed ID: 7281697)
1. [Encouraging results with cytostatic therapy in metastasizing breast cancer (author's transl)].
Michlmayr G; Kratzer H; Denz H; Huber H
Wien Klin Wochenschr; 1981 Mar; 93(6):205-7. PubMed ID: 7281697
[TBL] [Abstract][Full Text] [Related]
2. [Adriamycin-combination chemotherapy with or without immune stimulation by corynebacterium parvum in metastasizing carcinoma of the breast (author's transl)].
Mayr AC; Senn HJ; Gallmeier WM; Bruntsch U; Becher R; Drings P; Fritze D; Kaufmann M; Queisser W; Kempgens U
Dtsch Med Wochenschr; 1979 Dec; 104(49):1739-43. PubMed ID: 510206
[TBL] [Abstract][Full Text] [Related]
3. First, second and third line chemotherapy programs in metastatic breast carcinoma.
Rizel S; Sulkes A; Gez E; Brufman G; Biran S
Isr J Med Sci; 1981; 17(9-10):946-53. PubMed ID: 6171542
[TBL] [Abstract][Full Text] [Related]
4. A new six-drug antiblastic regimen (R 14) at low doses (micropolychemotherapy) compared to CMF in the treatment of metastatic breast cancer: phase III study.
Pannuti F; Iafelice G; Martoni A; Fruet F; Angelelli B; Casadei M
Chemioterapia; 1984 Aug; 3(4):216-9. PubMed ID: 6398121
[TBL] [Abstract][Full Text] [Related]
5. [Experiences with drug therapy of advanced metastatic carcinoma of the breast (author's transl)].
Nüvemann M; Fernholz HJ; Frik W
Med Klin; 1976 Oct; 71(40):1676-83. PubMed ID: 184372
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy of advanced breast cancer--actual results ].
Matthes ML; Lenk H; Gürtler R; Tanneberger S
Arch Geschwulstforsch; 1982 May; 52(3):241-6. PubMed ID: 6812538
[TBL] [Abstract][Full Text] [Related]
7. Treatment of metastatic breast cancer with adriamycin-cyclophosphamide induction followed by alternating combination therapy.
Abeloff MD; Ettinger DS
Cancer Treat Rep; 1977 Dec; 61(9):1685-9. PubMed ID: 340033
[TBL] [Abstract][Full Text] [Related]
8. [Cytostatic therapy in metastasizing breast cancer].
Gynning I; Mattsson W
Lakartidningen; 1978 Apr; 75(15):1512-5. PubMed ID: 651418
[No Abstract] [Full Text] [Related]
9. Activity of adriamycin in metastatic breast cancer resistant to a combination regimen with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prdnisone.
Frederiksen PL; Joergensen ST; Roesdahl K; Thomsen J; Mouridsen HT
Cancer Treat Rep; 1978 Mar; 62(3):449-50. PubMed ID: 348314
[No Abstract] [Full Text] [Related]
10. [Chemotherapy in primary and metastatic intrathoracic cancer].
Mannes P; Derriks R; Moens R; Laurent C
Ann Med Interne (Paris); 1976 Jan; 127(1):25-34. PubMed ID: 1008360
[TBL] [Abstract][Full Text] [Related]
11. [Cytostatic combination therapy in metastatic breast cancer].
Mouridsen HT
Ugeskr Laeger; 1973 Jun; 135(25):1336-40. PubMed ID: 4757127
[No Abstract] [Full Text] [Related]
12. Phase II study of combined vincristine, adriamycin, cyclophosphamide, and methotrexate with citrovorum factor factor rescue in metastatic breast cancer.
Mattsson W; Arwidi A; von Eyben F; Lindholm CE
Cancer Treat Rep; 1977 Nov; 61(8):1527-31. PubMed ID: 303543
[TBL] [Abstract][Full Text] [Related]
13. Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.
Smalley RV; Bartolucci AA
Eur J Cancer (1965); 1980; Suppl 1():141-6. PubMed ID: 7318861
[No Abstract] [Full Text] [Related]
14. [Combined drug/hormone therapy in metastatic breast cancer with vincristine, adriamycin, cyclophosphamide and high dose medroxyprogesterone acetate--VAC-MAP. Preliminary results of a phase II study of the German Cancer Society's Internal Medicine Oncology Task Force].
Wander HE; Nagel GA; Blossey HC; Kordilla F; Stamm S; Matthressen W; Weiss J
Onkologie; 1982 Aug; 5 Suppl():8-12. PubMed ID: 6752794
[TBL] [Abstract][Full Text] [Related]
15. [Control studies on the cytostatic combination therapy in metastasizing breast carcinoma].
Brunner KW; Martz G; Senn HJ; Obrecht P; Alberto P; Melchert F
Internist (Berl); 1973 Dec; 14(12):643-52. PubMed ID: 4593011
[No Abstract] [Full Text] [Related]
16. [Chemotherapy of metastasizing breast cancers. Indications and results].
Gallmeier WM; Bruntsch U; Schmidt CG
Dtsch Med Wochenschr; 1975 Jan; 100(2):35-41. PubMed ID: 1112210
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy for breast cancer.
Allegra JC; Lippman ME
Compr Ther; 1979 Feb; 5(2):13-7. PubMed ID: 428200
[TBL] [Abstract][Full Text] [Related]
18. [Chemotherapy of metastasizing breast cancer. Adriamycin mono and combination therapy after LMFP pretreatment].
Waibel PJ; Jungi WF; Senn HJ
Dtsch Med Wochenschr; 1983 Dec; 108(48):1827-32. PubMed ID: 6641535
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy of metastatic breast cancer in postmenopausal women: a controlled trial of cyclophosphamide versus a five-drug combination of cyclophosphamide, vincristine, methotrexate, 5-fluorouracil and prednisone.
Mouridsen HT; Palshof T
Prog Clin Biol Res; 1977; 12():459-66. PubMed ID: 335404
[No Abstract] [Full Text] [Related]
20. Antitumor effect of combination of cyclophosphamide, adriamycin and platinum (CAP) versus cyclophosphamide, adriamycin and 5-fluorouracil (CAF) in metastatic breast cancer.
Tzekova V; Velikova M; Koynov K; Micheva D; Donchev T
Neoplasma; 1991; 38(6):603-7. PubMed ID: 1766485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
